ENFN - Enfusion GAAP EPS of $0.01 misses by $0.02 revenue of $42.7M misses by $1.89M
2023-08-08 07:40:26 ET
- Enfusion press release ( NYSE: ENFN ): Q2 GAAP EPS of $0.01 misses by $0.02 .
- Revenue of $42.7M (+17.0% Y/Y) misses by $1.89M .
- FY23 Outlook:
- Revenue of $170-$175M
- Adj EBITDA of $30-$32M
For further details see:
Enfusion GAAP EPS of $0.01 misses by $0.02, revenue of $42.7M misses by $1.89M